Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Ruilong High-tech
- ·The full record, as it builds
Funding rounds
No funding rounds for Ruilong High-tech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ruilong High-tech
Manufacturer of anthraquinone products intended for industrial synthesis purposes. The company integrates large-scale production facilities, advanced equipment, comprehensive testing methods, and occupational safety systems, enabling industrial chemical producers to achieve consistent quality, enhanced safety, improved efficiency, reduced environmental impact, and reliable support for applications across hydrogen peroxide production, dye manufacturing, and other chemical sectors.
- Sector
- Healthcare
- HQ
- Lanzhou, China
- Founded
- 2021
- Website
- rarlon.cn.chemnet.com/
- Ownership
- Privately Held (backing)
Ruilong High-tech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ruilong High-tech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ruilong High-tech in its N-PORT filings yet. We sweep new filings monthly.